SWOT Analysis for Kronos Bio Inc

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
High Volume, High Gain

Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Declining Revenue every quarter for the past 2 quarters
Stocks Underperforming their Industry Price Change in the Quarter